About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, July 31st, 2015

The QualityStocks
Daily Stock List


SWK Holdings Corp. (SWKH)

Zacks, Wall Street Resources, Real Pennies, and FeedBlitz reported previously on SWK Holdings Corp. (SWKH), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Founded in 1996, SWK Holdings Corp. is a life science focused specialty finance company based in Dallas, Texas. It partners with ethical product marketers and royalty holders to provide flexible financing solutions at an attractive cost of capital to create long-term value for its business partners and its investors. SWK provides novel capital solutions to a broad array of life science companies, institutions and inventors. The Company lists on the OTC Markets’ Group’s OTCQB.

SWK Holdings, by way of its subsidiary, SWK Advisors LLC, provides non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. SWK Holdings believes its financing structures realize an optimal partnership for companies, institutions and inventors looking for capital for expansion or capital and estate planning through allowing its partners to monetize future cash flow with minimal dilution to their equity stakes.

SWK’s primary emphasis is on originating and investing in structured, asset-based debt transactions in the pharmaceutical and medical device space. This includes IP-based cash flow streams, synthetic royalties, as well as legacy product acquisitions.

The Company can invest at any point in the life cycle of a marketed product. This is from launch to mature, post-IP expiration. SWK’s transactions permit its counterparties to invest in higher return activities such as acquiring new technologies, financing development projects, and funding additional working capital needs. SWK’s specialty is in sub-$50 million opportunities that other structured finance investors customarily consider too small.

In May, SWK Holdings announced its Q1 2015 financial results. Total revenues increased by 58 percent to approximately $5.8 million for Q1 of 2015, versus $3.7 million for Q1 of 2014. Net income increased 55 percent to $2.3 million, or $0.02 per share for Q1 of 2015, versus $1.5 million, or $0.04 per share for Q1 of 2014.

Non-GAAP Adjusted net income increased 77 percent to $3.5 million, or $0.03 per share for the three months ending March 31, 2015, versus $2.0 million, or $0.05 per share for Q1 of 2014. Book value grew to $1.42 per share.

SWK Holdings Corp. (SWKH), closed Friday's trading session at $1.51, even for the day, on 19,305 volume with 17 trades. The average volume for the last 60 days is 54,557 and the stock's 52-week low/high is $1.12/$1.65.

Future Healthcare of America (FUTU)

RedChip and OTCPicks reported previously on Future Healthcare of America (FUTU), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Future Healthcare of America’s wholly-owned subsidiary, Interim Healthcare of Wyoming, Inc. (IHW), is an independent franchisee of Interim HealthCare. Interim provides a wide assortment of visiting nurse services to the elderly, wounded, and sick. It is one of the 300 independent home health agencies that make up the Interim HealthCare network. Future Healthcare of America is headquartered in Palm Beach, Florida. Its Interim Healthcare of Wyoming subsidiary is based in Casper, Wyoming, and Billings, Montana.

Future Healthcare of America’s objective is to grow the Company via acquisitions of healthcare businesses that can be positively impacted through operational efficiencies, easier access to growth capital, and effective implementation of technology. Its Interim HealthCare subsidiary is the nation’s oldest leading home care and medical staffing company.

Future Healthcare of America’s business consists of providing healthcare services for those in need. The Company records all revenue and expenses and provides all services under one umbrella. Future Healthcare of America continues to work to build a strong business that will offer a complementary package of new technology and traditional services.

Interim HealthCare’s independent franchisees employ greater than 75,000 health care workers. It provides nurses, therapists, aides, and other health care personnel. IHW provides home care services. This includes senior care and pediatric nursing; physical, occupational and speech therapy. It provides health care professionals at all skill levels. This includes registered nurses, therapists, LPN’s, and certified home health aides. 

Regarding Staffing, IHW offices provide nurses, nurse’s aides and management services to hospitals, prisons, schools, corporations, and health care facilities. IHW works with its clients should they decide they would like to hire its service professional on a full time basis. In addition to its professional team, the Company employs a management team at each facility to handle the daily direction of the office. This is provided by its Administrators. Furthermore, the Company has a Director of Nursing in each location.

Future Healthcare of America’s home healthcare business continues to be a major revenue generator as the nation’s population ages and new methods of patient data capture become important elements for delivering high quality, affordable healthcare services in a patient's home.

Recently, Future Healthcare of America announced that it signed a non-binding Letter of Intent (LOI) to acquire F3 & Associates, Inc.  F3 is a leading California-based provider of precision measurement, 3D visualization and data management services for critical, capital-intensive industrial assets including oil refineries, power plants and other high-traffic sites. Following the closing, the Company’s intention is to continue F3's asset intelligence and data management businesses, change its corporate name to F3, and replace at least a majority of the Company's Board of Directors with F3 appointees.

Future Healthcare of America also plans to spin-off its current healthcare business to its shareholders of record immediately before the Share Exchange closing. This is an action that will result in the current Future Healthcare of America business becoming a separately traded public company.

Future Healthcare of America (FUTU), closed Friday's trading session at $0.44, down 2.22%, on 9,003 volume with 5 trades. The average volume for the last 60 days is 23,412 and the stock's 52-week low/high is $0.02/$0.45.

Enumeral Biomedical Holdings, Inc. (ENUM)

Today we are reporting on Enumeral Biomedical Holdings, Inc. (ENUM), here at the QualityStocks Daily Newsletter.

OTC Bulletin Board listed Enumeral Biomedical Holdings, Inc. is discovering and developing novel antibody immunotherapies, which help the immune system attack diseased cells. The Company is building a pipeline of immunomodulators for the treatment of cancer and inflammatory diseases and taking advantage of the breadth of its technology via strategic collaborations. Its innovative platform enables it to identify and characterize promising new drugs relevant to cancer, infectious and inflammatory diseases. Enumeral Biomedical Holdings is based in Cambridge, Massachusetts.

The Company is enabling and hastening the discovery and development of novel antibody immunotherapies, or immunomodulators, which are validated with its human-driven immune profiling platform. Its immunoprofiling platform harnesses The Power of Human™. The Company believes that its cellular functional profiling techniques provide for a deeper understanding of the diversity of human responses and provide a more rational foundation to guide immunotherapy design and development. Its belief is that it has a unique ability to extensively interrogate the human immune microenvironment for candidate selection and validation.

Enumeral believes its unique capabilities enable it to measure drug effects in a patient-specific manner, providing the foundation for developing best-in-class product candidates, based on a fundamental understanding of how immunotherapies work in each patient. The core technology underlying its platform was developed at, and licensed from, the Massachusetts Institute of Technology, Harvard University, and Whitehead Institute for Biomedical Research and Massachusetts General Hospital.

Enumeral announced in January 2015 that it signed an agreement with Memorial Sloan Kettering Cancer Center. The agreement is part of Enumeral’s Phase II Small Business Innovation Research (SBIR) grant with the National Cancer Institute. The agreement will deploy Enumeral’s human tissue immune-oncology profiling technology at MSK in the laboratory of Jedd D. Wolchok, MD, PhD.  Dr. Wolchok is the Chief of Melanoma and Immunotherapeutics in the Clinical Investigation Department.

Enumeral is building a pipeline centered on next-generation checkpoint modulators, with initial targets including PD-1, Tim3, Lag-3, OX40, and VISTA. In developing these agents, its researchers apply a proprietary immune profiling technology platform that measures functioning of the human immune system at the level of individual cells. This provides important insights for candidate selection and validation. Enumeral aims to move its lead PD-1 antagonist into clinical testing during the second half of 2016, with additional programs moving toward IND-enabling studies.

Yesterday, Enumeral Biomedical Holdings announced that it appointed Mr. Robert J. Easton to its Board of Directors. Mr. Easton is a recognized leader in the life sciences and healthcare industries. He presently serves as Co-Chairman of Bionest Partners, Inc. Bionest is a consulting firm he co-founded. Bionest’s specialty is strategic planning for pharmaceutical, medical device and diagnostic companies.

Enumeral Biomedical Holdings, Inc. (ENUM), closed Friday's trading session at $0.5989, even for the day. The average volume for the last 60 days is 26,930 and the stock's 52-week low/high is $0.302/$2.25.

Breathe eCig Corp. (BVAP)

SmallCapVoice, Shiznit Stocks, OTPicks, WallstreetSurfers, Penny Stock General, Fast Money Alerts, Stock Shock and Awe, and Jet-Life Penny Stocks reported on Breathe eCig Corp. (BVAP), and we choose to report on the Company as well, here at the QualityStocks Daily Newsletter.

Breathe eCig Corp. has created a new ground-breaking e-cigarette. The Company’s Chief Executive Officer and Founder is Josh Kimmel, whose expertise is in handcrafting flavors. Breathe eCig® from DNA Precious Metals (DNAP) is operating in the e-cig marketplace. Breathe consumables are crafted in the United States. Breathe eCig is based in Knoxville, Tennessee and the Company lists on the OTC Markets’ OTCQB.

Breathe, LLC was established in October of 2013 and Breathe eCig Corp. established on December 31, 2014. Breathe, LLC entered into a Bill of Sale to transfer 100 percent of the assets to Breathe eCig Corp, on December 31, 2014.  

On January 15, 2015, DNA Precious Metals, Inc. (DNAP) announced that it acquired all of the issued and outstanding equity interests in Breathe, LLC in exchange for the issuance of 150 million shares of DNAP common stock. This represents approximately 56 percent of DNAP’S issued and outstanding shares of common stock.

All of Breathe's eliquid content is manufactured in a Food and Drug Administration (FDA) certified factory in eastern Tennessee. The Company has proprietary patent pending technology and home grown, hand crafted flavors. Breathe’s goal is to differentiate the Company and create a recognized brand specializing in organic and natural flavored e-Cigarettes.

Tauriga Sciences and Breathe earlier announced that the two companies entered into a license agreement to co-develop and co-commercialize a new cannabidiol (CBD) e-cigarette.  The new product will use Breathe's patent pending, proprietary device, which dispenses a measured and consistent amount of active ingredient per puff. It additionally features an optional childproofing device.

Tauriga will be responsible for the active ingredient. Tauriga will source and qualify the CBD oil and will formulate the contents of the pre-filled cartridges and refill units. Tauriga Sciences and Breathe will share the net profits equally from the CBD e-cigarette product line. Tauriga is a diversified life sciences company.

In May, Breathe eCig announced the completed formation of its two wholly owned subsidiaries: Breathe IP Corp. and Breathe MD Corp.  Breathe IP will focus on the development of intellectual property (patents) and Breathe MD will focus on the development of medical devices and technology.  The formation of these two subsidiaries represents incremental new operating businesses and diversification. The Company's emphasis remains on the E-Cigarette space.   

This week, Breathe eCig announced that its products have successfully entered the New York City Metropolitan area market via its distribution partnership with Metro Tablet, Inc.  Metro Tablet has primarily targeted independent supermarkets and convenience stores to initially penetrate the New York City marketplace with Breathe's E-Cigarette product line and proprietary flavors.

Breathe eCig Corp. (BVAP), closed Friday's trading session at $0.091, up 51.67%, on 338,652 volume with 25 trades. The average volume for the last 60 days is 481,285 and the stock's 52-week low/high is $0.02/$0.18.

Fuel Performance Solutions, Inc. (IFUE)

FeedBlitz reported previously on Fuel Performance Solutions, Inc. (IFUE), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Fuel Performance Solutions, Inc. centers on providing fuel performance solutions to large industrial consumers of diesel fuel and bio-diesel fuel blends in the rail, road transport, stationary power generation, and marine industries. The Company previously went by the name International Fuel Technology, Inc. It changed its name to Fuel Performance Solutions, Inc. in February 2014. The Company has its corporate headquarters in St. Louis, Missouri.

Fuel Performance Solutions’ core product lines are DiesoLiFT™, GasoLiFT™, PerfoLiFT™, and KeroLiFT. DiesoLiFT™10 is its combustion enhancing formulation. It increases fuel economy, reduces harmful emissions, and reduces maintenance costs when mixed with diesel fuel and bio-diesel fuel blends. GasoLiFT™ 10 is its additive formula for gasoline and ethanol fuel blends. It delivers the same major benefits delivered by all of the Company’s surfactant-based additives.

The PerfoLiFT™ BD-Series is Fuel Performance Solutions formulation specifically designed to provide first-rate oxidation stability and deposit control benefits when mixed with bio-diesel fuel (pure and in blends). KeroLiFT™10 is engineered for use with heating oils for use in boilers and other oil-fired equipment applications.

Fuel Performance Solutions recorded record revenues of $1.8 million for the fiscal year ended December 31, 2014. This represents an increase of more than 150 percent in comparison to fiscal year 2013 revenues of $704,000. Sales of the DiesoLiFT™ product line, its proprietary fuel additive formulations for increasing fuel economy in diesel fuel and bio-diesel fuel blends, increased by close to 800 percent for fiscal year 2014 in comparison to fiscal year 2013.

Recently, Fuel Performance Solutions announced that the Fuel Efficiency Management (FEM) program, a joint program between the Company and distribution partner Unipart Rail, is ready for deployment across the rail and road transport sectors in the United Kingdom (U.K.) and Europe. The FEM program is a comprehensive fuel efficiency program. It will provide a tanker to vehicle tank fuel solutions service to end-users of diesel fuel.

Axel Farhi, Fuel Performance Solutions’ Director of Global Business Development, said, “Given the changing fuel dynamics in the U.K. and Europe and the subsequent problems end-users are experiencing across all industries as a result, we see a huge market opportunity for the FEM program. This changing fuel dynamic and its effect on fuel and equipment is the reason that Unipart Rail and FPS developed the FEM program.”

Fuel Performance Solutions, Inc. (IFUE), closed Friday's trading session at $0.051, down 3.77%, on 60,100 volume with 7 trades. The average volume for the last 60 days is 80,281 and the stock's 52-week low/high is $0.16/$0.026.


The QualityStocks
Company Corner


On the Move Systems, Inc. (OMVS)

The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $2.25, up 22.95%, on 311,577 volume with 465 trades. The stock’s average daily volume over the past 60 days is 25,906, and its 52-week low/high is $0.2501/$11.04.

On the Move Systems, Inc. (OMVS) specializes in the development of cutting-edge technology to transform and synchronize freight supply chain operations for a broad range of industries. The company is exploring new online tools to reduce costs and increase convenience in the tourism and travel industry, as well as new opportunities in trucking. OMVS works with a premier group of international providers to offer its services in two key divisions: Trucking Logistics and Inter-modal Freight.

Logistics are critical to the success of any operation. OMVS's Trucking Logistics division operates as one of the most competitive, full-service transportation logistics providers in the United States. Utilizing the company's ISTx Platform, this division helps customers strategize how to get from one point to another, as well as solves some of the toughest logistics challenges on the road today. OMVS's Trucking Logistics technology provides customers increased visibility, minimal-cost route effectiveness, and delivery assurance.

OMVS's Intermodal Freight division offers seamless cargo continuation, tracking, shipping and receiving of goods anywhere in the world. The company's customer service teams and drivers communicate through the ISTx Platform allowing for flexibility, control and monitoring of each freight shipment. OMVS continues to research and explore the most effective and resourceful tools in order to effectively serve customers with unique shipping requirements in the billion dollar trucking industry.

In his more than 20 years of experience, OMVS president and CEO Robert Wilson has cultivated vast expertise as an executive and financial consultant for companies in aviation, energy, oil and gas, IT and healthcare. In addition to his work valuing and assessing small-to-middle market companies, Wilson has also served as both an officer and director of such client companies. Wilson applies his expertise in the transportation business and investment banking to spearhead OMVS's new initiative to create a new kind of online transportation platform to an international market Disclaimer

On the Move Systems, Inc. Company Blog

On the Move Systems, Inc. News:

OMVS: Mid-Market Shippers Good Fit for Upcoming On-Demand Trucking Market

OMVS Finding Strong Market Potential for Shared Economy Courier Service

OMVS: Shared Economy Courier Service Offers Great Market Potential

Growblox Sciences, Inc. (GBLX)

The QualityStocks Daily Newsletter would like to spotlight Growblox Sciences, Inc. (GBLX). Today, Growblox Sciences, Inc. closed trading at $0.335, up 4.69%, on 120,225 volume with 29 trades. The stock’s average daily volume over the past 60 days is 84,162, and its 52-week low/high is $0.151/$1.51.

Growblox Sciences, Inc. (GBLX), a biopharmaceutical research and development company, is focused on creating safe, standardized pharmaceutical-grade cannabis-based therapies for various medical conditions. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.

The company’s GrowBLOX technology suite includes the TissueBLOX, GrowBLOX, and CureBLOX equipment. Together, these components provide unparalleled control and monitoring of cannabis cultivation throughout the plant's life-cycle. These patent pending processes were designed to produce a safe and consistent cannabis product under cGMP guidelines. Utilizing a computer-regulated system that optimizes the nutrients, water, temperature, and gas levels, the GrowBLOX suite produces cannabis with more active ingredients per pound than traditional cultivation methods.

Also, based on an analysis of preclinical and clinical data from thousands of peer-reviewed studies, Growblox Sciences has identified the most effective profiles of cannabinoids and terpenes for the treatment of conditions within seven therapeutic categories. As a result of this extensive research and the analysis of the active ingredient profiles of 30,000 Cannabis strains in conjunction with a major testing lab, the company will be able to provide patients with natural cannabis strains containing the ideal ratios for treating specific diseases or symptoms.

Another significant advantage held by the company stems from an accelerated drug development program to finish in 3-5 years instead of the 15-20 years typically seen in traditional pharmaceutical development programs. Armed with an intellectual property strategy that takes full advantage of the design of the GrowBLOX technology suite and protects the valuable foundation laid, Growblox Sciences has positioned itself well for long-term success in the burgeoning cannabis space. Disclaimer

Growblox Sciences, Inc. Company Blog

Growblox Sciences, Inc. News:

GrowBLOX Sciences is Making Big Moves in Anticipation of Opening Nevada Cultivation Facility

GrowBLOX Receives Funding to Complete Construction of Nevada Cultivation Facility

GrowBLOX Announces Deployment of Commercial Units

One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.004, up 5.26%, on 2,902,077 volume with 27 trades. The stock’s average daily volume over the past 60 days is 10,793,366, and its 52-week low/high is $0.0008/$0.034.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

Production Complete, Prettie Girls! Tween Scene Dolls En Route To The US

The One World Doll Project Announces New Orders from Amazon.com

One World Holdings, Inc. to File 8k Answering Shareholder Questions About Company Share Structure

View Systems, Inc. (VSYM)

The QualityStocks Daily Newsletter would like to spotlight View Systems, Inc. (VSYM). Today, View Systems, Inc. closed trading at $0.0038, off by 2.06%, on 900,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 541,559, and its 52-week low/high is $0.0036/$0.024.

View Systems, Inc. (VSYM) is a leading security technology products company with “state-of-the-art” technological solutions for modern security problems. Targeting the challenging business opportunities in the opening decades of the 21st century and beyond, View Systems has solutions for law enforcement facilities such as correctional institutions as well as other government agencies, schools, courthouses, event and sports venues, the military and commercial businesses.

The senior management team is comprised of successful businessmen with decades of business and professional experience in the security industry. The approach used by View Systems utilizes the expertise of this team to provide innovative solutions to security problems with reliable “cutting edge” products in conjunction with client-oriented security consulting services.

The company’s flagship product, ViewScan, is an advanced walk-through Concealed Weapons Detection System (CWD) that greatly simplifies the process of discriminating suspicious items from harmless ones. The highly sensitive, completely passive sensor technology powering the system accurately detects the location and number of threat objects such as knives, guns and razor blades while ignoring personal artifacts like coins, keys and belt buckles. A portable version of this system has only a fifteen minute setup time using only a screwdriver and it easily fits inside a golf size case.

Experts say the security industry has been the fastest-growing sector of the global economy during the past decade. Today, it is conservatively estimated to be a $100 billion-a-year industry and growing. As the business environment continues to get more complex, especially in foreign markets, View Systems is strategically positioned to capitalize on unsurpassed opportunity. Disclaimer

View Systems, Inc. Company Blog

View Systems, Inc. News:

View Systems, Inc. Files for Patent, Begins Manufacturing of Enhanced ViewScan Product

View Systems Continues to Install Its Proprietary Scanning Systems Nationwide

View Systems, Inc. (VSYM) Announces Engagement of QualityStocks Investor Relations Services

Galenfeha, Inc. (GLFH)

The QualityStocks Daily Newsletter would like to spotlight Galenfeha, Inc. (GLFH). Today, Galenfeha, Inc. closed trading at $0.26, even for the day, on 950 volume with 2 trades. The stock’s average daily volume over the past 60 days is 50,749, and its 52-week low/high is $0.1011/$4.00.

Galenfeha, Inc. (GLFH) is an engineering, product development, and manufacturing company that provides innovative solutions for oil and natural gas production, as well as stored energy products across a number of different industries. The company provides these products and services through its stored energy and oil & gas division.

Through its stored energy division, Galenfeha offers one of the most powerful, environmentally friendly battery systems in the market. The batteries have onboard computers, are inherently safe, internally temperature regulated, have optional GPS monitoring capabilities, offer significant weight reduction of up to 50%, and are engineered specifically for each type of application. Features include 100% “green” chemistry, RoHS compliancy, and active short circuit protection control.

Through its oil and gas division, the company offers chemical injection pumps that merge the perceived benefits of a hybrid, electric over pneumatic system. Galenfeha management believes the combination of the two parameter control systems represents a measurable shift in efficiency, reliability, cost management, and profitability to individual well locations as well as entire production fields. The combined technologies have demonstrated increased chemical injection accuracy, reducing chemical contamination in the production process while controlling cost and waste.

The company’s unwavering dedication is to continuously develop products that perform better than conventional solutions while also reducing environmental impact. Leveraging the management team’s wealth of resources and relationships, Galenfeha is well positioned for continued growth as the company aims to expand in both the stored energy and oil & gas industries. Disclaimer

Galenfeha, Inc. Company Blog

Galenfeha, Inc. News:

Galenfeha, Inc. Products Offered by Leading Power and Automation Company

Galenfeha Stored Energy Solutions Enters Aviation Industry

Galenfeha Broadens Oil and Gas Industry Penetration


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



INO.com Market Report


Orbit Stocks


Wall Street Resources

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251